Molecular subtypes predict second breast events of ductal carcinoma in situ after breast‐conserving surgery

Molecular subtypes predict second breast events of ductal carcinoma in situ after breast‐conserving surgery

Abstract Purpose Currently, the prognostic value of molecular subtypes in ductal carcinoma in situ (DCIS) remains unclear. In this study, we explored whether molecular subtypes could predict second breast events (SBEs) in patients after breast‐conserving surgery (BCS). Methods From January 2008 to D...

Full description

Bibliographic Details
Main Authors: Yilan Yang, Xu Zhao, Xuanyi Wang, Kairui Jin, Jurui Luo, Zhaozhi Yang, Xin Mei, Jinli Ma, Zhimin Shao, Zhen Zhang, Xingxing Chen, Xiaomao Guo, Xiaoli Yu
Format: Article
Language:English
Published: Wiley 2022-07-01
Series:Cancer Medicine
Subjects:
DCIS
HER2 overexpression
molecular subtypes
second breast events
Online Access:https://doi.org/10.1002/cam4.4651

Internet

https://doi.org/10.1002/cam4.4651

Similar Items